| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.0067 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |